1B1 Stock Overview
An investment holding company, provides medical services primarily in Singapore. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
HC Surgical Specialists Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.28 |
| 52 Week High | S$0.32 |
| 52 Week Low | S$0.24 |
| Beta | 0.058 |
| 11 Month Change | 5.77% |
| 3 Month Change | 3.77% |
| 1 Year Change | -1.79% |
| 33 Year Change | -51.75% |
| 5 Year Change | -48.60% |
| Change since IPO | -50.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1B1 | SG Healthcare | SG Market | |
|---|---|---|---|
| 7D | 1.9% | -0.2% | 0.9% |
| 1Y | -1.8% | -11.8% | 14.9% |
Return vs Industry: 1B1 exceeded the SG Healthcare industry which returned -11.8% over the past year.
Return vs Market: 1B1 underperformed the SG Market which returned 14.9% over the past year.
Price Volatility
| 1B1 volatility | |
|---|---|
| 1B1 Average Weekly Movement | 5.6% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in SG Market | 14.7% |
| 10% least volatile stocks in SG Market | 2.2% |
Stable Share Price: 1B1 has not had significant price volatility in the past 3 months compared to the SG market.
Volatility Over Time: 1B1's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Sieu Min Heah | www.hcsurgicalspecialists.com |
HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other general and specialized medical services.
HC Surgical Specialists Limited Fundamentals Summary
| 1B1 fundamental statistics | |
|---|---|
| Market cap | S$42.30m |
| Earnings (TTM) | S$3.85m |
| Revenue (TTM) | S$19.05m |
11.0x
P/E Ratio2.2x
P/S RatioIs 1B1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1B1 income statement (TTM) | |
|---|---|
| Revenue | S$19.05m |
| Cost of Revenue | S$9.80m |
| Gross Profit | S$9.25m |
| Other Expenses | S$5.40m |
| Earnings | S$3.85m |
Last Reported Earnings
May 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.025 |
| Gross Margin | 48.55% |
| Net Profit Margin | 20.19% |
| Debt/Equity Ratio | 8.9% |
How did 1B1 perform over the long term?
See historical performance and comparisonDividends
5.1%
Current Dividend Yield55%
Payout RatioDoes 1B1 pay a reliable dividends?
See 1B1 dividend history and benchmarks| HC Surgical Specialists dividend dates | |
|---|---|
| Ex Dividend Date | Nov 08 2024 |
| Dividend Pay Date | Nov 25 2024 |
| Days until Ex dividend | 13 days |
| Days until Dividend pay date | 4 days |
Does 1B1 pay a reliable dividends?
See 1B1 dividend history and benchmarks